Metformin’s Brain Link: New Pathway Behind a 60-Year-Old Diabetes Drug

TL;DR Summary
A Science Advances study in mice shows metformin lowers glucose via brain Rap1 signaling in the ventromedial hypothalamus, not just liver or gut; deleting Rap1 in this brain region abolishes metformin’s effect, while direct brain administration also lowers glucose, suggesting brain-targeted mechanisms could unlock new diabetes therapies and possibly aging benefits.
Reading Insights
Total Reads
0
Unique Readers
4
Time Saved
6 min
vs 7 min read
Condensed
96%
1,237 → 51 words
Want the full story? Read the original article
Read on ScienceAlert